Price to Sales ratio Analysis of aTyr Pharma Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Dec-23
Excellent PS
0.100
Period Ending - Dec-22
Very Poor PS
5.47
Growth
-98.18 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
5642.09
PS Analysis of aTyr Pharma Inc
| P/S Ratio of aTyr Pharma Inc with value of 5642.09 indicates that stock price is high compared to sales of the company and may be overvalued. |
| PS Ratio of LIFE drastically fell by -98.18 % this year. |
| PS Ratio with value of 3549.60 was highest in Year Dec-21 in last Five Years. |
| PS Ratio with value of 0.100 was lowest in Year Dec-23 in last Five Years. |
| Latest PS Ratio with value of 0.100 is lower than Average PS of 714.57 in last five years. |
Other PS Related Info of LIFE that may interest you.
aTyr Pharma Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LIFE | 2.0 | 1.93 | 3.63 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Price to Sales of aTyr Pharma Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| PS | 0.100 | 5.47 | 3549.60 | 1.75 | 15.90 | 0 | 0 |
| Change | -98.18 % | -99.85 % | 202465 % | -88.98 % |
FY Chart of Price to Sales of aTyr Pharma Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)